About this trial
Alzheimer's disease is the leading cause of dementia worldwide. The first cognitive function to be affected is memory. As the disease progresses, other cognitive systems are affected, leading to a gradual loss of independence for the patient. This loss of independence is at the heart of the psychosocial and medico-economic challenges posed by Alzheimer's disease. Functional independence refers to the patient's ability to perform activities of daily living. The evolution of autonomy varies significantly from one individual to another, and a specific, personalized assessment is necessary in order to offer appropriate care and services. There is a link between patient autonomy and psycho-behavioral disorders. Early identification of loss of autonomy in connection with psycho-behavioral disorders would allow specific treatment to be put in place.
The study hypothesis is that there is a link between changes in smartphone data and changes in the independence of patients with AD.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 60 years
Patient consulting on routine care at a memory resource and research center for Alzheimer's disease defined by cognitive memory complaints from the patient or their family and friends, evidence of impaired verbal episodic memory storage in FCSRT defined by a sum of FR values less than 17/48 and a sum of CR values less than 40/48 compared to the patient's age and socio-cultural level and no criteria on other neuropsychological tests, progressive decline over at least 6 months affecting independence, and if a brain MRI, a lumbar puncture, and/or an 18FDG PET scan were performed as part of the patient's routine care, the results must be consistent with a diagnosis of MA.
Patient with a smartphone for their exclusive use that is compatible with the installation of the IMASMART application on Android
No sensory impairment (vision or hearing impairment) that could compromise the use of a smartphone
Disqualifiers
Inability to perform the Mini-Mental State Examination or score < 17
Other neurodegenerative disorders
Severe, unstable psychiatric disorders
Terminal phase of a severe illness
Trial population
Patients receiving routine care at a memory resource and research center for Alzheimer's disease who own an Android smartphone.
Trial design
Cohort
Prospective
Treatments tested in this trial
Data collection
Other interventionCollection of Android smartphone usage
Neuropsychological assesment
Other interventionMMSE, FCSRT, FAB, TMT, verbal fluency test, Rey figure, BBEP, langage assesments and HAD scale
Autonomy questionnaire
Other interventionIADL Amsterdam assessed by the caregiver
Treatment groups
Trial outcomes
Primary outcomes
Comparison of changes in smartphone usage data and battery life collected at 0 and 18 months
To measure the relationship between variations in smartphone usage data-represented as a single parameter created through a mathematical combination-and variations in the Amsterdam IADL questionnaire between 0 and 18 months.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: